(Q54346621)

28 May 2018

title

Assessing responses to treatment of opportunistic mycoses and salvage strategies. (English)

1 reference

28 May 2018

author name string

Baldeep Wirk

series ordinal

1

1 reference

28 May 2018

John R Wingard

series ordinal

2

1 reference

28 May 2018

publication date

1 December 2011

1 reference

28 May 2018

Current infectious disease reports

published in

1 reference

28 May 2018

volume

13

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

492-503

1 reference

28 May 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Changes in causes of death over time after treatment for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

When primary antifungal therapy fails

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Learning from our failures: the antifungal treatment conundrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Comparison of 2 Studies of Treatment of Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0217-5

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

21 January 2018

1 reference

12 December 2020

Empiric antifungal therapy for the neutropenic patient

1 reference

12 December 2020

Should the guidelines for management of central venous catheters in patients with candidemia be changed now?

1 reference

12 December 2020

Prognostic factors for invasive aspergillosis in patients with haematological malignancies

1 reference

12 December 2020

Antifungal prophylaxis in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Prevention of fungal infections in the immunocompromised host

1 reference

12 December 2020

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

1 reference

12 December 2020

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

1 reference

12 December 2020

Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults

1 reference

12 December 2020

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications

1 reference

12 December 2020

10.1007/S11908-011-0217-5

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018